Cargando…
TRIF as a Novel Modulator of Liver Inflammation and Fibrosis
Autor principal: | Török, Natalie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404095/ https://www.ncbi.nlm.nih.gov/pubmed/28462370 http://dx.doi.org/10.1016/j.jcmgh.2017.03.002 |
Ejemplares similares
-
TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017) -
Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021) -
Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling
por: Bettink, Stephanie I., et al.
Publicado: (2022) -
TRIF Deficiency does not Affect Severity of Ovalbumin-induced Airway Inflammation in Mice
por: Kim, Tae-Hyoun, et al.
Publicado: (2014) -
Retraction: TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling
Publicado: (2021)